Mustang Bio Inc. (MBIO) Financial Statements (2026 and earlier)

Company Profile

Business Address 95 SAWYER RD
WALTHAM, MA 02453
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17,266,0006,839,0006,234,00075,656,000109,618,00097,804,000
Cash and cash equivalent17,266,0006,839,0006,234,00075,656,000109,618,00097,804,000
Restricted cash and investments    1,000,0001,000,0001,000,000
Receivables217,000     
Asset, held-for-sale, not part of disposal group  1,165,000    
Other undisclosed current assets 110,000602,0005,112,0002,196,0001,088,000730,000
Total current assets:17,593,0008,606,00011,346,00078,852,000111,706,00099,534,000
Noncurrent Assets
Operating lease, right-of-use asset  81,0001,566,0002,918,0001,050,0001,088,000
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization  371,0003,218,0009,391,00011,052,0008,028,000
Restricted cash and investments   750,0001,000,0001,000,0001,000,000
Other noncurrent assets  250,000833,000261,000362,000250,000
Other undisclosed noncurrent assets   29,000   
Total noncurrent assets:  702,0006,396,00013,570,00013,464,00010,366,000
Other undisclosed assets      
TOTAL ASSETS:17,593,0009,308,00017,742,00092,422,000125,170,000109,900,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,411,0009,486,00014,017,00013,731,0009,744,0008,747,000
Accounts payable3,510,0007,464,0006,322,0006,833,0003,512,0003,518,000
Other undisclosed accounts payable and accrued liabilities1,901,0002,022,0007,695,0006,898,0006,232,0005,229,000
Debt      278,000
Other liabilities2,503,0002,667,000    
Due to related parties✕✕✕✕766,000723,000490,000
Other undisclosed current liabilities  456,0001,354,000612,000348,000 
Total current liabilities:7,914,00012,609,00015,371,00015,109,00010,815,0009,515,000
Noncurrent Liabilities
Long-term debt and lease obligation    27,436,0001,685,0001,950,000
Long-term debt, excluding current maturities    27,436,000  
Liabilities, other than long-term debt150,000572,0002,248,0003,604,000270,000 
Deferred revenue150,000150,000270,000270,000270,000 
Operating lease, liability  422,0001,978,0003,334,0001,685,0001,950,000
Total noncurrent liabilities:150,000572,0002,248,00031,040,0001,955,0001,950,000
Total liabilities:8,064,00013,181,00017,619,00046,149,00012,770,00011,465,000
Equity
Equity, attributable to parent, including:9,529,000(3,873,000)123,00046,273,000112,400,00098,435,000
Common stock      7,000
Common stock, value, subscriptions 273,000611,000591,0001,109,0004,329,0007,939,000
Additional paid in capital407,899,000392,234,000380,502,000374,522,000359,906,000275,963,000
Accumulated deficit(398,644,000)(396,723,000)(380,971,000)(329,369,000)(251,844,000)(185,474,000)
Other undisclosed equity, attributable to parent1,0005,0001,00011,0009,000 
Total equity:9,529,000(3,873,000)123,00046,273,000112,400,00098,435,000
TOTAL LIABILITIES AND EQUITY:17,593,0009,308,00017,742,00092,422,000125,170,000109,900,000

Income Statement (P&L) (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating expenses(2,432,000)(16,245,000)(49,260,000)(76,159,000)(66,723,000)(56,806,000)
Operating loss:(2,432,000)(16,245,000)(49,260,000)(76,159,000)(66,723,000)(56,806,000)
Nonoperating income (expense)511,000493,000(2,342,000)(1,366,000)353,000(3,209,000)
Other nonoperating income     353,000 
Interest and debt expense  (5,000)(4,109,000)(3,359,000) (3,917,000)
Loss from continuing operations before income taxes:(1,921,000)(15,757,000)(55,711,000)(80,884,000)(66,370,000)(63,932,000)
Income tax expense (27,000)     
Other undisclosed loss from continuing operations      
Loss from continuing operations:(1,948,000)(15,757,000)(55,711,000)(80,884,000)(66,370,000)(63,932,000)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(66,370,000)(63,932,000)
Net loss:(1,948,000)(15,757,000)(55,711,000)(80,884,000)(66,370,000)(63,932,000)
Other undisclosed net income attributable to parent27,0005,0004,109,0003,359,000 3,917,000
Net loss available to common stockholders, diluted:(1,921,000)(15,752,000)(51,602,000)(77,525,000)(66,370,000)(60,015,000)

Comprehensive Income (USD)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(1,948,000)(15,757,000)(55,711,000)(80,884,000)(66,370,000)(63,932,000)
Comprehensive loss, net of tax, attributable to parent:(1,948,000)(15,757,000)(55,711,000)(80,884,000)(66,370,000)(63,932,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: